1. Home
  2. ABR vs WVE Comparison

ABR vs WVE Comparison

Compare ABR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$2.86

Market Cap

809.7M

Sector

Real Estate

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$3.18

Market Cap

673.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
WVE
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
809.7M
673.9M
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
ABR
WVE
Price
$2.86
$3.18
Analyst Decision
Hold
Strong Buy
Analyst Count
5
21
Target Price
$3.25
★ $17.68
AVG Volume (30 Days)
★ 7.3M
2.8M
Earning Date
10-30-2026
10-27-2026
Dividend Yield
★ 23.29%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,704,000.00
Revenue This Year
N/A
$19.15
Revenue Next Year
$3.86
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 149.43
52 Week Low
$2.53
$3.04
52 Week High
$11.93
$21.73

Technical Indicators

Market Signals
Indicator
ABR
WVE
Relative Strength Index (RSI) 30.57 32.30
Support Level $2.53 $3.04
Resistance Level $5.38 $4.07
Average True Range (ATR) 0.20 0.16
MACD 0.06 0.04
Stochastic Oscillator 35.75 24.12

Price Performance

Historical Comparison
ABR
WVE

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: